We are live on ! Find out more
ALDX icon

Aldeyra Therapeutics
ALDX

136 hedge funds and large institutions have $511M invested in Aldeyra Therapeutics in 2021 Q2 according to their latest regulatory filings, with 49 funds opening new positions, 44 increasing their positions, 28 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

133% more first-time investments, than exits

New positions opened: 49 | Existing positions closed: 21

59% more call options, than puts

Call options by funds: $6.71M | Put options by funds: $4.21M

57% more repeat investments, than reductions

Existing positions increased: 44 | Existing positions reduced: 28

36% more capital invested

Capital invested by funds: $377M → $511M (+$134M)

26% more funds holding

Funds holding: 108 → 136 (+28)

11.46% more ownership

Funds ownership: 67.13% → 78.59% (+11%)

0% more funds holding in top 10

Funds holding in top 10: 4 → 4 (0)

Holders
136
Holders Change
+28
Holders Change %
+25.93%
% of All Funds
2.37%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.07%
New
49
Increased
44
Reduced
28
Closed
21
Calls
$6.71M
Puts
$4.21M
Net Calls
+$2.5M
Net Calls Change
+$3.29M

Top Buyers

1
BlackRock
BlackRock
New York
+$26.7M
2
PA
Perceptive Advisors
New York
+$14.4M
3
EAM
Eagle Asset Management
Florida
+$13.1M
4
WP
Woodline Partners
California
+$11.8M
5
Goldman Sachs
Goldman Sachs
New York
+$11.2M

Top Sellers

1
APM
Avidity Partners Management
Texas
-$13.3M
2
Citadel Advisors
Citadel Advisors
Florida
-$2.76M
3
ECM
ExodusPoint Capital Management
New York
-$1.86M
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$1.85M
5
Millennium Management
Millennium Management
New York
-$1.6M
Name Holding Trade Value Shares
Change 		Change in
Stake
PA
1
Perceptive Advisors
New York
$112M +$14.4M +1,200,000 +14%
FLAM
2
First Light Asset Management
Minnesota
$39.3M +$10.2M +847,458 +32%
BlackRock
3
BlackRock
New York
$37.1M +$26.7M +2,222,456 +211%
State Street
4
State Street
Massachusetts
$35.5M +$8.54M +710,115 +29%
Vanguard Group
5
Vanguard Group
Pennsylvania
$30.6M +$7.74M +643,955 +31%
WP
6
Woodline Partners
California
$19.4M +$11.8M +978,529 +134%
APM
7
Avidity Partners Management
Texas
$16.4M -$13.3M -1,102,000 -43%
Fidelity Investments
8
Fidelity Investments
Massachusetts
$13.6M +$5.32M +442,302 +58%
Two Sigma Investments
9
Two Sigma Investments
New York
$12.8M +$2.99M +248,772 +28%
EAM
10
Eagle Asset Management
Florida
$12.3M +$13.1M +1,085,518 New
Two Sigma Advisers
11
Two Sigma Advisers
New York
$11.5M +$2.17M +180,100 +22%
Goldman Sachs
12
Goldman Sachs
New York
$11.4M +$11.2M +931,972 +1,232%
Geode Capital Management
13
Geode Capital Management
Massachusetts
$10.2M +$6.01M +500,080 +126%
ACM
14
Altium Capital Management
New York
$9.79M +$3.8M +315,795 +58%
TLP
15
Tri Locum Partners
New York
$9.27M +$9.84M +818,025 New
Assenagon Asset Management
16
Assenagon Asset Management
Luxembourg
$7.23M +$7.03M +584,539 +1,087%
GTC
17
Ghost Tree Capital
New York
$6.8M -$601K -50,000 -8%
PM
18
Prosight Management
Texas
$6.74M +$1.46M +121,793 +26%
KCM
19
Knoll Capital Management
Florida
$6.45M – – –
Verition Fund Management
20
Verition Fund Management
Connecticut
$5.98M +$1.34M +111,114 +27%
Northern Trust
21
Northern Trust
Illinois
$5.7M +$4.96M +412,862 +458%
AG
22
Artal Group
Luxembourg
$4.89M +$5.19M +431,894 New
Millennium Management
23
Millennium Management
New York
$4.65M -$1.6M -133,275 -25%
JJIJ
24
Johnson & Johnson Innovation - JJDC
New Jersey
$4.47M – – –
N
25
Nuveen
North Carolina
$3.94M +$4.19M +348,125 New
1
2 3 4 5

ALDX Hedge Fund Activity: Q2 2021 in Review

136 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Aldeyra Therapeutics (ALDX) for Q2 2021, worth a combined $511M — up 36% from $377M a quarter earlier.

Buyers outnumbered sellers: 49 funds opened new ALDX positions and 21 closed out — a net gain of 28 holders — while 44 added to existing stakes and 28 trimmed.

The largest buyer was BlackRock, adding an estimated $26.7M. The largest seller was Avidity Partners Management, cutting an estimated $13.3M.

  • 136 institutional investors held Aldeyra Therapeutics (ALDX) as of Q2 2021, up from 108 in Q1 2021.
  • Funds reported $511M of Aldeyra Therapeutics stock for Q2 2021, up 36% quarter-over-quarter.
  • 49 funds opened new Aldeyra Therapeutics positions in Q2 2021 and 21 closed out, a net change of +28 holders.
  • The largest Aldeyra Therapeutics buyer in Q2 2021 was BlackRock, an estimated $26.7M added.
  • The largest Aldeyra Therapeutics seller in Q2 2021 was Avidity Partners Management, an estimated $13.3M sold.

Based on aggregated 13F filings for Q2 2021.